| Financial Year |
March 31 2023 |
| Monetary Funds |
342,806,781.49 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
8,485,187.15 |
| Accounts Receivable |
492,282,663.56 |
| Advances to Suppliers |
12,036,885.15 |
| Other Receivables |
22,386,646.59 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
398,765,622.53 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
78,723,806.94 |
| Total Current Assets |
1,357,808,422.91 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
3,026,474.19 |
| Long-term Equity Investment |
149,801,117.50 |
| Investment Properties |
-- |
| Fixed Assetes |
606,946,042.56 |
| Under-construction Projects |
20,284,197.30 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
50,790,592.79 |
| R&D expenses |
4,003,452.36 |
| Goodwill |
3,093,938.80 |
| Long-Term Deferred and Prepaid Expenses |
62,293,589.75 |
| Deferred Income Tax Assets |
27,068,600.76 |
| Other Non-Current Assets |
23,920,218.76 |
| Sub-Total of Non-Current Assets |
1,406,969,030.18 |
| Total Assets |
2,764,777,453.09 |
| Short-Term Loans |
203,752,441.70 |
| Trading Financial liabilities |
188,018.81 |
| Notes Payable |
-- |
| Accounts Payable |
910,797,945.49 |
| Accounts Received In Advance |
125,443.47 |
| Employee Compensation Payable |
71,335,468.74 |
| Taxes Payable |
9,046,615.49 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
39,649,203.16 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
95,085,836.85 |
| Other Current Liabilities |
3,395,950.05 |
| Sub-Total of Current Liabilities |
1,338,450,920.12 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
131,691.95 |
| Deferred Income Tax Liabilities |
19,950,026.05 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
231,424,248.61 |
| Total Liabilities |
1,569,875,168.73 |
| Paid-In Capital(Or Share Stock) |
803,169,608.00 |
| Capital Surplus |
2,990,073,544.22 |
| Surplus Reserve |
141,513,537.76 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,715,179,872.53 |
| Minority Stockholder's Interest |
-22,589,709.15 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,217,491,993.51 |
| Owner's Equity（Stockholder's Equity） |
1,194,902,284.36 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,764,777,453.09 |
